Evaluation of a Gemcitabine‐Doxorubicin‐Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines

Combination chemotherapy with gemcitabine (Gem), doxorubicin (Dox), and paclitaxel (Pac) (GAT) has been considered attractive as first‐line treatment in metastatic breast cancer. We compared the potential of various schedules of GAT to induce apoptosis on MDA‐MB–231, MCF7, and T47D human breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano, Maria J., Sánchez‐Rovira, Pedro, Algarra, Ignacio, Jaén, Ana, Lozano, Ana, Gaforio, José J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927032/
https://www.ncbi.nlm.nih.gov/pubmed/12036452
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01291.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927032/
https://www.ncbi.nlm.nih.gov/pubmed/12036452
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01291.x

Ejemplares similares